Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months
Clinical trial NCT04909021 · UNKNOWN
Trial details
- NCT number
- NCT04909021
- Sponsor
- Meissa Vaccines, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2023-10-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.